Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: A meta-regression analysis of randomized trials

被引：60

作者：

De Luca, G ^{[1
]}

Suryapranata, H ^{[1
]}

Stone, GW ^{[1
]}

Antoniucci, D ^{[1
]}

Tcheng, JE ^{[1
]}

Neumann, FJ ^{[1
]}

Bonizzoni, E ^{[1
]}

Topol, EJ ^{[1
]}

Chiariello, M ^{[1
]}

机构：

[1] Univ Naples Federico II, Div Cardiol, I-80131 Naples, Italy

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 03期

关键词：

D O I：

10.1016/j.jacc.2005.11.018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：685 / 686

页数：2

共 6 条

[1] Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation [J].

Antoniucci, D ;

Valenti, R ;

Migliorini, A ;

Moschi, G ;

Trapani, M ;

Dovellini, EV ;

Bolognese, L ;

Santoro, GM .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) :353-357

[2] Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction - A meta-analysis of randomized trials [J].

De Luca, G ;

Suryapranata, H ;

Stone, GW ;

Antoniucci, D ;

Tcheng, JE ;

Neumann, FJ ;

Van de Werf, F ;

Antman, EM ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14) :1759-1765

[3] Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction - Every minute of delay counts [J].

De Luca, G ;

Suryapranata, H ;

Ottervanger, JP ;

Antman, EM .

CIRCULATION, 2004, 109 (10) :1223-1225

[4] Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction [J].

Henriques, JPS ;

Zijlstra, F ;

Ottervanger, JP ;

de Boer, MJ ;

van't Hof, AWJ ;

Hoorntje, JCA ;

Suryapranata, H .

EUROPEAN HEART JOURNAL, 2002, 23 (14) :1112-1117

[5] TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy [J].

Morrow, DA ;

Antman, EM ;

Charlesworth, A ;

Cairns, R ;

Murphy, SA ;

de Lemos, JA ;

Giugliano, RP ;

McCabe, CH ;

Braunwald, E .

CIRCULATION, 2000, 102 (17) :2031-2037

[6] Advanced methods in meta-analysis: multivariate approach and meta-regression [J].

van Houwelingen, HC ;

Arends, LR ;

Stijnen, T .

STATISTICS IN MEDICINE, 2002, 21 (04) :589-624

← 1 →